-
1
-
-
0033763097
-
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23
-
ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat Genet 2000; 26: 345-348.
-
(2000)
Nat Genet
, vol.26
, pp. 345-348
-
-
Consortium, A.1
-
2
-
-
14344279878
-
Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia
-
Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001; 98: 6500-6505.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 6500-6505
-
-
Shimada, T.1
Mizutani, S.2
Muto, T.3
-
3
-
-
29144500469
-
Structural and biochemical properties of fibroblast growth factor
-
Yamashita T. Structural and biochemical properties of fibroblast growth factor Ther Apher Dial 2005; 9: 313-318.
-
(2005)
Ther Apher Dial
, vol.9
, pp. 313-318
-
-
Yamashita, T.1
-
4
-
-
0035186837
-
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
-
White KE, Carn G, Lorenz-Depiereux B et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001; 60: 2079-2086.
-
(2001)
Kidney Int
, vol.60
, pp. 2079-2086
-
-
White, K.E.1
Carn, G.2
Lorenz-Depiereux, B.3
-
5
-
-
1642416884
-
Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism
-
Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568.
-
(2004)
J Clin Invest
, vol.113
, pp. 561-568
-
-
Shimada, T.1
Kakitani, M.2
Yamazaki, Y.3
-
6
-
-
9244240970
-
Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders
-
Bai X, Miao D, Li J et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004; 145: 5269-5279.
-
(2004)
Endocrinology
, vol.145
, pp. 5269-5279
-
-
Bai, X.1
Miao, D.2
Li, J.3
-
7
-
-
3042634460
-
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
-
Larsson T, Marsell R, Schipani E et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004; 145: 3087-3094.
-
(2004)
Endocrinology
, vol.145
, pp. 3087-3094
-
-
Larsson, T.1
Marsell, R.2
Schipani, E.3
-
8
-
-
2142746439
-
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
-
Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 429-435
-
-
Shimada, T.1
Hasegawa, H.2
Yamazaki, Y.3
-
9
-
-
35848947037
-
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells
-
Krajisnik T, Bjo rklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
-
(2007)
J Endocrinol
, vol.195
, pp. 125-131
-
-
Krajisnik, T.1
Bjo Rklund, P.2
Marsell, R.3
-
10
-
-
36849017126
-
The parathyroid is a target organ for FGF-23 in rats
-
Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF-23 in rats. J Clin Invest 2007; 117: 4003-4008.
-
(2007)
J Clin Invest
, vol.117
, pp. 4003-4008
-
-
Ben-Dov, I.Z.1
Galitzer, H.2
Lavi-Moshayoff, V.3
-
11
-
-
0141844575
-
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
-
Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426.
-
(2003)
J Biol Chem
, vol.278
, pp. 37419-37426
-
-
Liu, S.1
Guo, R.2
Simpson, L.G.3
-
12
-
-
85047691059
-
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
-
Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 683-692.
-
(2003)
J Clin Invest
, vol.112
, pp. 683-692
-
-
Riminucci, M.1
Collins, M.T.2
Fedarko, N.S.3
-
13
-
-
33646367420
-
Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D
-
Liu S, Tang W, Zhou J et al. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17: 1305-1315.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1305-1315
-
-
Liu, S.1
Tang, W.2
Zhou, J.3
-
14
-
-
84859832389
-
Effects of dietary phosphate and calcium intake on fibroblast growth factor-23
-
Vervloet MG, van Ittersum FJ, Bu ttler RM et al. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 2010; 6: 83-89.
-
(2010)
Clin J Am Soc Nephrol
, vol.6
, pp. 83-89
-
-
Vervloet, M.G.1
Van Ittersum, F.J.2
Bu Ttler, R.M.3
-
15
-
-
15944376583
-
Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
-
Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005; 90: 1519-1524.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1519-1524
-
-
Ferrari, S.L.1
Bonjour, J.P.2
Rizzoli, R.3
-
16
-
-
33845322655
-
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
-
Nishida Y, Taketani Y, Yamanuka-Okumura H et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 2006; 70: 2141-2147.
-
(2006)
Kidney Int
, vol.70
, pp. 2141-2147
-
-
Nishida, Y.1
Taketani, Y.2
Yamanuka-Okumura, H.3
-
17
-
-
79551500014
-
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
-
Isakova T, Gutierrez OM, Smith K et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 2010; 26: 584-591.
-
(2010)
Nephrol Dial Transplant
, vol.26
, pp. 584-591
-
-
Isakova, T.1
Gutierrez, O.M.2
Smith, K.3
-
18
-
-
33747719260
-
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
-
Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 3144-3149
-
-
Antoniucci, D.M.1
Yamashita, T.2
Portale, A.A.3
-
19
-
-
20444404265
-
Genetic dissection of phosphate-and vitamin D-mediated regulation of circulating FGF-23 concentrations
-
Yu X, Sabbagh Y, Davis SI et al. Genetic dissection of phosphate-and vitamin D-mediated regulation of circulating FGF-23 concentrations. Bone 2005; 36: 971-977.
-
(2005)
Bone
, vol.36
, pp. 971-977
-
-
Yu, X.1
Sabbagh, Y.2
Davis, S.I.3
-
20
-
-
33845631059
-
Klotho converts canonical FGF receptor into a specific receptor for FGF-23
-
Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF-23. Nature 2006; 444: 770-774.
-
(2006)
Nature
, vol.444
, pp. 770-774
-
-
Urakawa, I.1
Yamazaki, Y.2
Shimada, T.3
-
21
-
-
0030724491
-
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
-
Kuro-o M, Matsumura Y, Yamazaki Y et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51.
-
(1997)
Nature
, vol.390
, pp. 45-51
-
-
Kuro-O, M.1
Matsumura, Y.2
Yamazaki, Y.3
-
22
-
-
9144248333
-
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
-
Shimada T, Urakawa I, Yamazaki Y et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 2004; 314: 409-414.
-
(2004)
Biochem Biophys Res Commun
, vol.314
, pp. 409-414
-
-
Shimada, T.1
Urakawa, I.2
Yamazaki, Y.3
-
23
-
-
78049481921
-
Parathyroid Klotho and FGFreceptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
-
Krajisnik T, Olauson H, Mirza MA et al. Parathyroid Klotho and FGFreceptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78: 1024-1032.
-
(2010)
Kidney Int
, vol.78
, pp. 1024-1032
-
-
Krajisnik, T.1
Olauson, H.2
Mirza, M.A.3
-
24
-
-
74449094013
-
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
-
Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77: 211-218.
-
(2010)
Kidney Int
, vol.77
, pp. 211-218
-
-
Galitzer, H.1
Ben-Dov, I.Z.2
Silver, J.3
-
26
-
-
0032489424
-
Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein
-
Shiraki-Iida T, Aizawa H, Matsumura Y et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 1998; 424: 6-10.
-
(1998)
FEBS Lett
, vol.424
, pp. 6-10
-
-
Shiraki-Iida, T.1
Aizawa, H.2
Matsumura, Y.3
-
27
-
-
34247232767
-
Klotho: An antiaging protein involved in mineral and vitamin D metabolism
-
Torres PU, Irie D, Molina-Bletry V et al. Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 2007; 71: 730-737.
-
(2007)
Kidney Int
, vol.71
, pp. 730-737
-
-
Torres, P.U.1
Irie, D.2
Molina-Bletry, V.3
-
28
-
-
1642352496
-
Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides
-
Tohyama O, Imura A, Iwano A et al. Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J Biol Chem 2004; 279: 9777-9784.
-
(2004)
J Biol Chem
, vol.279
, pp. 9777-9784
-
-
Tohyama, O.1
Imura, A.2
Iwano, A.3
-
29
-
-
27144440831
-
The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel
-
Chang Q, Hoefs S, van der Kemp AW et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005; 310: 490-493.
-
(2005)
Science
, vol.310
, pp. 490-493
-
-
Chang, Q.1
Hoefs, S.2
Van Der Kemp, A.W.3
-
30
-
-
0346849707
-
Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system
-
Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17: 2393-2403.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 2393-2403
-
-
Tsujikawa, H.1
Kurotaki, Y.2
Fujimori, T.3
-
31
-
-
77956642900
-
Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
-
Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450.
-
(2010)
FASEB J
, vol.24
, pp. 3438-3450
-
-
Hu, M.C.1
Shi, M.2
Zhang, J.3
-
32
-
-
40149102029
-
Klotho as a regulator of oxidative stress and senescence
-
Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008; 389: 233-241.
-
(2008)
Biol Chem
, vol.389
, pp. 233-241
-
-
Kuro-O, M.1
-
33
-
-
27844561111
-
Regulation of oxidative stress by the anti-aging hormone klotho
-
Yamamoto M, Clark JD, Pastor JV et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 2005; 280: 38029-38034.
-
(2005)
J Biol Chem
, vol.280
, pp. 38029-38034
-
-
Yamamoto, M.1
Clark, J.D.2
Pastor, J.V.3
-
34
-
-
78650600602
-
Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity
-
Kusaba T, Okigawa M, Matui A et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci U S A 2010; 107: 19308-19313.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 19308-19313
-
-
Kusaba, T.1
Okigawa, M.2
Matui, A.3
-
35
-
-
0034130405
-
Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases
-
Nagai R, Saito Y, Ohyama Y et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000; 57: 738-746.
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 738-746
-
-
Nagai, R.1
Saito, Y.2
Ohyama, Y.3
-
36
-
-
0035986324
-
Production of nitric oxide, but not prostacyclin, is reduced in klotho mice
-
Nakamura T, Saito Y, Ohyama Y et al. Production of nitric oxide, but not prostacyclin, is reduced in klotho mice. Jpn J Pharmacol 2002; 89: 149-156.
-
(2002)
Jpn J Pharmacol
, vol.89
, pp. 149-156
-
-
Nakamura, T.1
Saito, Y.2
Ohyama, Y.3
-
37
-
-
79953138206
-
Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice
-
Doi S, Zou Y, Togao O et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011; 286: 8655-8665.
-
(2011)
J Biol Chem
, vol.286
, pp. 8655-8665
-
-
Doi, S.1
Zou, Y.2
Togao, O.3
-
38
-
-
2342599742
-
Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression
-
Takeshita K, Fujimori T, Kurotaki Y et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004; 109: 1776-1782.
-
(2004)
Circulation
, vol.109
, pp. 1776-1782
-
-
Takeshita, K.1
Fujimori, T.2
Kurotaki, Y.3
-
39
-
-
79953268951
-
Phosphate and klotho
-
Kuro-o M. Phosphate and Klotho. Kidney Int Suppl 2011; 121: S20-S23.
-
(2011)
Kidney Int Suppl
, vol.121
-
-
Kuro-O, M.1
-
40
-
-
34548497123
-
Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study
-
Fliser D, Kollerits B, Never U et al. Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18: 2600-2608.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2600-2608
-
-
Fliser, D.1
Kollerits, B.2
Never, U.3
-
41
-
-
79951889923
-
FGF-23 as a predictor of renal outcome in diabetic nephropathy
-
Titan SM, Zatz R, Graciolli FG et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2010; 6: 241-247.
-
(2010)
Clin J Am Soc Nephrol
, vol.6
, pp. 241-247
-
-
Titan, S.M.1
Zatz, R.2
Graciolli, F.G.3
-
43
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
-
44
-
-
67650892239
-
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
-
Mirza MA, Larsson A, Lind L et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009; 205: 385-390.
-
(2009)
Atherosclerosis
, vol.205
, pp. 385-390
-
-
Mirza, M.A.1
Larsson, A.2
Lind, L.3
-
45
-
-
70349656941
-
Relationship between circulating FGF-23 and total body atherosclerosis in the community
-
Mirza MA, Hansen T, Johansson L et al. Relationship between circulating FGF-23 and total body atherosclerosis in the community. Nephrol Dial Transplant 2009; 24: 3125-3131.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 3125-3131
-
-
Mirza, M.A.1
Hansen, T.2
Johansson, L.3
-
46
-
-
70450230670
-
Serum intact FGF-23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
-
Mirza MA, Larsson A, Melhus H et al. Serum intact FGF-23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009; 207: 546-551.
-
(2009)
Atherosclerosis
, vol.207
, pp. 546-551
-
-
Mirza, M.A.1
Larsson, A.2
Melhus, H.3
-
47
-
-
79953046736
-
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men
-
Mirza MA, Karlsson MK, Mellstrom D et al. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res 2011; 26: 857-864.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 857-864
-
-
Mirza, M.A.1
Karlsson, M.K.2
Mellstrom, D.3
-
48
-
-
77956884451
-
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
-
Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78: 679-685.
-
(2010)
Kidney Int
, vol.78
, pp. 679-685
-
-
Yilmaz, M.I.1
Sonmez, A.2
Saglam, M.3
-
50
-
-
79953880208
-
Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
-
Kirkpantur A, Balci M, Gurbuz CA et al. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011; 26: 1346-1354.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1346-1354
-
-
Kirkpantur, A.1
Balci, M.2
Gurbuz, C.A.3
-
51
-
-
77958565641
-
Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease
-
Kanbay M, Nicoleta M, Selcoki Y et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1780-1786.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1780-1786
-
-
Kanbay, M.1
Nicoleta, M.2
Selcoki, Y.3
-
52
-
-
4444308167
-
Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism
-
Sato T, Tominaga Y, Ueki T et al. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 2004; 44: 481-487.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 481-487
-
-
Sato, T.1
Tominaga, Y.2
Ueki, T.3
-
53
-
-
77957993384
-
PTH increases FGF-23 gene expression and mediates the high-FGF-23 levels of experimental kidney failure: A bone parathyroid feedback loop
-
Lavi-Moshayoff V, Wasserman G, Meir T et al. PTH increases FGF-23 gene expression and mediates the high-FGF-23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010; 299: F882-F889.
-
(2010)
Am J Physiol Renal Physiol
, vol.299
-
-
Lavi-Moshayoff, V.1
Wasserman, G.2
Meir, T.3
-
54
-
-
31544450766
-
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF-23 in renal failure rats
-
Nagano N, Miyata S, Abe M et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF-23 in renal failure rats. Kidney Int 2006; 69: 531-537.
-
(2006)
Kidney Int
, vol.69
, pp. 531-537
-
-
Nagano, N.1
Miyata, S.2
Abe, M.3
-
55
-
-
77749334660
-
Early control of PTH and FGF-23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy
-
Oliveira RB, Cancela AL, Graciolli FG et al. Early control of PTH and FGF-23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 2010; 5: 286-291.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 286-291
-
-
Oliveira, R.B.1
Cancela, A.L.2
Graciolli, F.G.3
-
56
-
-
77955110868
-
Fibroblast growth factor 23 in hemodialysis patients: Effects of phosphate binder, calcitriol and calcium concentration in the dialysate
-
Cancela AL, Oliveira RB, Graciolli FG et al. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 2011; 117: c74-c82.
-
(2011)
Nephron Clin Pract
, vol.117
-
-
Cancela, A.L.1
Oliveira, R.B.2
Graciolli, F.G.3
-
57
-
-
79961052017
-
Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients
-
Gonzalez-Parra E, Gonzalez-Casaus ML, Galan A et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transplant 2011; 26: 2567-2571.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2567-2571
-
-
Gonzalez-Parra, E.1
Gonzalez-Casaus, M.L.2
Galan, A.3
-
58
-
-
60749130276
-
Mortality reduction by vitamin D receptor activation in end-stage renal disease: A commentary on the robustness of current data
-
Vervloet MG, Twisk JW. Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data. Nephrol Dial Transplant 2009; 24: 703-706.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 703-706
-
-
Vervloet, M.G.1
Twisk, J.W.2
-
59
-
-
77951726222
-
Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
-
Voigt M, Fischer DC, Rimpau M et al. Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 2010; 56: 775-788.
-
(2010)
Histopathology
, vol.56
, pp. 775-788
-
-
Voigt, M.1
Fischer, D.C.2
Rimpau, M.3
-
60
-
-
65649103814
-
Initial FGF-23-mediated signaling occurs in the distal convoluted tubule
-
Farrow EG, Davis SI, Summers LJ et al. Initial FGF-23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20: 955-960.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 955-960
-
-
Farrow, E.G.1
Davis, S.I.2
Summers, L.J.3
-
61
-
-
84859753990
-
Development of Klotho-FGFR1/3 dependent resistance to FGF-23 in human aortic smooth muscle cells exposed to calcifying stress
-
Lim K, Lu TS, Zehnder D et al. Development of Klotho-FGFR1/3 dependent resistance to FGF-23 in human aortic smooth muscle cells exposed to calcifying stress. J Am Soc Nephrol 2010; 21: 140A.
-
(2010)
J Am Soc Nephrol
, vol.21
-
-
Lim, K.1
Lu, T.S.2
Zehnder, D.3
-
62
-
-
78651408919
-
Klotho deficiency causes vascular calcification in chronic kidney disease
-
Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 124-136
-
-
Hu, M.C.1
Shi, M.2
Zhang, J.3
|